Precision Biologics Revenue and Competitors
Claim your profile
Estimated Revenue & Valuation
- Precision Biologics's estimated annual revenue is currently $2.6M per year.
- Precision Biologics's estimated revenue per employee is $439,167
Employee Data
- Precision Biologics has 6 Employees.
- Precision Biologics grew their employee count by -60% last year.
Precision Biologics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.8M | 80 | 31% | N/A | N/A |
#2 | $2.9M | 31 | 29% | $1.8M | N/A |
#3 | $1.7M | 9 | 0% | N/A | N/A |
#4 | $2.6M | 39 | 15% | N/A | N/A |
#5 | $1.7M | 9 | 0% | N/A | N/A |
#6 | N/A | 3 | 0% | N/A | N/A |
#7 | $0.9M | 10 | 11% | $21.4M | N/A |
#8 | $84M | 438 | -4% | N/A | N/A |
#9 | $2.9M | 46 | 39% | N/A | N/A |
#10 | $3.1M | 18 | 6% | N/A | N/A |
What Is Precision Biologics?
Precision Biologics is a Biotechnology company located in 5910 N Central Expy, Dallas, Texas, United States.
keywords:N/AN/A
Total Funding
6
Number of Employees
$2.6M
Revenue (est)
-60%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Precision Biologics News
2022-04-20 - Ambrx Biopharma Inc. Reports Full Year 2021 Financial ...
Ambrx has truly positioned itself as a leader in the antibody drug conjugate and precision biologics space, working together with our...
2022-04-19 - Ambrx Biopharma Inc. and Quantum Leap Healthcare ...
... a clinical stage biopharmaceutical company using an expanded genetic code technology platform to create Engineered Precision Biologics,...
2022-04-17 - Ambrx Biopharma Inc. to Release Full Year 2021 Financial ...
... a clinical stage biopharmaceutical company using an expanded genetic code technology platform to create Engineered Precision Biologics,...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.4M | 6 | N/A | N/A |
#2 | $0.8M | 6 | N/A | N/A |
#3 | $0.4M | 6 | N/A | N/A |
#4 | $0.4M | 6 | N/A | N/A |
#5 | $0.4M | 6 | N/A | N/A |